Install
News of the Day Anticipated therapies and not-so-anticipated dominate July PBAC agenda GSK brings Melbourne discovered treatment 'home' to Australian patients New government report reveals the emerging impact of generational reform Health department quietly launches major review of blood products supply Budget reveals
- 39articles · 30d
- 12+ hour agolatest article
- Aug 17, 2026earliest in window
- 92%with images
- 132avg words
- Medical 34
- Health & Wellness 29
- Health 27
- Business & Industrial 10
- Economy, Business & Finance 5
- Finance & Business 4
- Science & Technology 4
- Human Interest 1
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends
12+ hour, 5+ min ago (131+ words) PharmaDispatch Entropy's psychedelic infusion keeps binge eating disorder at bay three months after treatment ends Six patients who had lived with binge eating disorder for as long as two decades sat down for two infusions of an experimental psychedelic drug....
Noxopharm moves lupus skin therapy toward next human trial
12+ hour ago (117+ words) PharmaDispatch Noxopharm moves lupus skin therapy toward next human trial Noxopharm announced that its lead experimental therapy, SOF-SKN, will advance to an extension clinical study in patients with cutaneous lupus erythematosus, a painful, disfiguring skin condition for which no targeted…...
Diabetes and cancer blood tests reach WA and NT patients under new Healius deal
13+ hour, 1+ min ago (137+ words) PharmaDispatch Diabetes and cancer blood tests reach WA and NT patients under new Healius deal Perth-based medical technology company Proteomics International has begun selling two of its diagnostic blood tests directly to patients in Western Australia and the Northern Territory,…...
FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug
12+ hour, 50+ min ago (124+ words) PharmaDispatch FDA clears Telix's Pixclara as the world's first approved brain cancer imaging drug Telix Pharmaceuticals has secured landmark approval from the United States Food and Drug Administration for Pixclara, making it the first FDA-sanctioned imaging agent for glioma, the…...
Rare genetic motor neurone disease treatment finally reaches Australian patients
3+ day, 22+ hour ago (138+ words) PharmaDispatch Rare genetic motor neurone disease treatment finally reaches Australian patients Australians living with a rare genetic form of motor neurone disease will gain access to an innovative treatment from 1 October, with the reimbursement of Biogen's QALSODY (tofersen). … 'You can't…...
Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence
4+ day, 20+ hour ago (159+ words) PharmaDispatch Australia secures sovereign viral vector manufacturing as VVMF wins TGA licence A Sydney company has become the first in Australia to earn a manufacturing licence for viral vectors, a milestone it says strengthens the nation's capacity to make advanced…...
Melbourne oncologist takes the reins at Australia's private cancer physicians body
4+ day, 20+ hour ago (154+ words) PharmaDispatch Melbourne oncologist takes the reins at Australia's private cancer physicians body After twelve years steering the Private Cancer Physicians of Australia through some of the most consequential fights in Australian cancer policy, Christopher Steer has handed the presidency to…...
Guilt over this enduring failure is the correct response
5+ day, 13+ hour ago (157+ words) PharmaDispatch Guilt over this enduring failure is the correct response We live in a wealthy country where this situation has been allowed to persist. Responsibility is not shared equally. Those with the authority to design, operate and change the system…...
A review recommendation that should be reconsidered because of time
1+ week, 2+ hour ago (138+ words) PharmaDispatch A review recommendation that should be reconsidered because of time A plan built around expanding the traditional evaluator pipeline, without first testing what AI can absorb, risks locking in permanent headcount and cost against a workload that may shrink…...
Bupa to discontinue international referrals for 'Doctors on Demand' telehealth
1+ week, 8+ hour ago (139+ words) PharmaDispatch Bupa to discontinue international referrals for 'Doctors on Demand' telehealth Vitura Health has updated investors, confirming that Bupa will discontinue its international patient referrals from the Doctors on Demand telehealth business. … Five years, 1,826 days, and we are still going…...